Table 2.
Population | Cohort 1 (mefloquine; N = 23) | Cohort 2 (infectivity control; N = 6) |
---|---|---|
Total number of AEs | 112 | 22 |
Total number of subjects with any AE | 20 (87.0%) | 6 (100.0%) |
Total number of subjects with grade 1 AE | 19 (82.6%) | 6 (100.0%) |
Total number of subjects with grade 2 AE | 13 (56.5%) | 4 (66.7%) |
Total number of subjects with grade 3 AE | 2 (8.7%) | 0 (0.0%) |